Plus Therapeutics News and Activities

Plus Therapeutics is a company listed under the stock ticker PSTV (US).

View the org chart displaying its 22 main executives

Most searched biographies at Plus Therapeutics

• Marc Hedrick, President, Chief Executive Officer and Director
• Richard Hawkins, Chairman of the Board
• Kyle Guse, Director

Popular executive movements at Plus Therapeutics

• Randy Goodman has joined the company as Vice President, Value Strategy and Health Economics and Outcomes Research  (posted on April 15 2026).
• Yvonne Martinez, Senior Accountant, has left the company  (posted on April 9 2026).
• Eric Daniels will join the company as Chief Development Officer on Apr. 20, 2026  (posted on April 9 2026).

Click here to view some more movements at Plus Therapeutics

Create your alert
to follow the executive moves at Plus Therapeutics.

Plus Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Plus Therapeutics

• PLUS THERAPEUTICS, Inc. Press Releases Plus Therapeutics to Participate in Upcoming Virtual ConferencesPlus Therapeutics to Participate in Upcoming Virtual ConferencesPlus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Busine
• PLUS THERAPEUTICS, Inc. - News
• PLUS THERAPEUTICS, Inc. - News
• PLUS THERAPEUTICS, Inc. - Press Releases
• PLUS THERAPEUTICS, Inc. - News
• PLUS THERAPEUTICS, Inc. Press Releases Plus Therapeutics to Participate in Upcoming November Investor ConferencesPlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial UpdatePlus Therapeutics Announces Formation of Scientific
• View more press releases Close

Social media about Plus Therapeutics

• Plus Therapeutics on Wikipedia, Google News & Yahoo Finance
• Plus Therapeutics on LinkedIn, X (Twitter) & YouTube